Assembly of multimeric von Willebrand factor directs sorting of P- selectin

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 7, 2000, Pages 1763-1768

  Hop, Caroline ^a   Guilliatt, Andrea ^b   Daly, Martina ^b   De Leeuw, Hubert P ^c   Brinkman, Herm Jan M ^c   Peake, Ian R ^b   Van Mourik, Jan A ^c   Pannekoek, Hans ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c CENTRAL LABORATORY   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

P selectin; Protein sorting; von Willebrand factor; Weibel Palade bodies

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MUTANT PROTEIN; PADGEM PROTEIN; PROTEIN KINASE C; VON WILLEBRAND FACTOR;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELETION MUTANT; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION; PROTEIN SECRETION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WEIBEL PALADE BODY;

EID: 0033927564     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.7.1763     Document Type: Article

References (35)

1. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217-246.
2. Loesberg C, Gonsalves MD, Zandbergen J, Willems C, van Aken WG, Stel HV, van Mourik JA, de Groot PhG. The effect of calcium on the secretion of factor VIII-related antigen by cultured endothelial cells. Biochim Biophys Acta. 1983;63:160-168.
3. 2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. J Clin Invest. 1987;79:600-608.
4. Federici AB, Bader R, Coliberti ML, de Marco L, Mannucci PM. Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimer size. Br J Haematol. 1989;73:93-99.
5. Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. J Cell Biol. 1964;23:101-112.
6. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel Palade bodies of human endothelial cells. J Cell Biol. 1982;95:355-360.
7. McCarrol DR, Levin EG, Montgomery RR. Endothelial cell synthesis of von Willebrand antigen-II, von Willebrand factor and von Willebrand factor/von Willebrand antigen II complex. J Clin Invest. 1985;75: 1089-1095.
8. Ewenstein BM, Warhol MJ, Handin RI, Pober JS. Composition of von Willebrand factor storage organelle (Weibel-Palade body) cultured from umbilical vein endothelial cells. J Cell Biol. 1987;104:1423-1433.
9. Metzelaar MJ, Wijngaard PLJ, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC. CD63 antigen: a novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem. 1991;266:3239-3245.
10. Vischer UM, Wagner DD. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1993;82:1184-1190.
11. Wolff B, Burns AR, Middleton J, Rot A. Endothelial cell 'memory' of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med. 1998;188:1757-1762.
12. Rosnoblet C, Vischer UM, Gerard RD, Irminger JC, Halban PA, Kruithof EKO. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler Thromb Vasc Biol. 1999; 19:1796-1803.
13. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP-140) is a component of Weibel Palade bodies of human endothelial cells. Blood. 1989;73:1109-1112.
14. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is located in Weibel-Palade bodies. J Clin Invest. 1989;84:92-99.
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
16. Fox SB, Turner GD, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J Pathol. 1995;177:369-376.
17. Shimomura A, Ikeda K, Suzuki H, Nakabayashi S, Oshima T, Furukawa M, Takasaka T, Ando N, Ohtani H, Nagura H. Expression of adhesion molecules in nonallergic chronic sinusitis. Laryngoscope. 1997;107: 1519-1524.
18. Li X, Zhou T, Hao C, Dong D, Cheng F, Chen S. Significance of P-selectin expression in human glomerulonephritis. Chin Med J. 1997; 110:512-514.
19. Wagner DD, Saffaripour S, Bonfanti R, Sadler JW, Cramer EM, Chapman B, Mayadas TM. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell. 1991;46:403-413.
20. Voorberg J, Fontijn R, Calafat J, Jansen H, van Mourik JA, Pannekoek H. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J. 1993;12:749-758.
21. Hop C, Fontijn R, van Mourik JA, Pannekoek H. Polarity of constitutive and regulated von Willebrand factor secreted by transfected MDCK-II cells. Exp. Cell Res. 1997;230:352-361.
22. Bubenik J, Baresova M, Viklicky V, Jakoubkova, J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer. 1973;11:765-773.
23. Voorberg J, Fontijn R, van Mourik JA, Pannekoek H. Domains involved in multimer assembly of von Willebrand factor (vWF): multimerization is independent of dimerization. EMBO J. 1990;9:797-803.
24. Voorberg J, Fontijn R, Calafat J, Jansen H, van Mourik JA, Pannekoek H. Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxyl-terminal 151 amino acids. J Cell Biol. 1991;113:195-205.
25. Maniatis T, Fritsch EF, Sambrook J. In: Molecular Cloning: A Laboratory Handbook. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
26. Borchiellini A, Fijnvandraat K, ten Cate JW, Pajkrt D, van Deventer SJH, Pasterkamp G, Meijer-Huizinga F, Zwart-Huinink L, Voorberg J, van Mourik JA. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood. 1996;88: 2951-2958.
27. Koedam JA, Cramer EM, Briend E, Furie B, Furie BC, Wagner DD. P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated pathway in AtT-20 cells. J Cell Biol. 1992;116: 617-625.
28. Natori S, Huttner WB. Chromogranin B (secretogranin I) promotes sorting to the regulated secretory pathway of processing intermediates derived from a peptide hormone precursor. Proc Natl Acad Sci U S A. 1996;93:4431-4436.
29. Glombik MM, Krömer A, Salm T, Huttner WB, Gerdes H-H. The disulfide-bonded loop of chromogranin B mediates membrane binding and directs sorting from the trans-Golgi network to secretory granules. EMBO J. 1999;18:1059-1070.
30. Rosenberg JB, Foster PA, Kaufman RJ. Vokac EA, Moussali M, Kroner PA, Montgomery RR. Intracellular trafficking of factor VIII to von Willebrand factor storage granules. J Clin Invest. 1998;101:613-624.
31. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leucocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541-554.
32. Johnson RC, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, Herz J, Hynes RO, Wagner DD. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest. 1997;99:1037-1043.
33. Nageh MF, Sandbergh ET, Marotti KR, Lin AH, Melchior EP, Bullard DC, Beaudet AL. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 1997;17:1517-1520.
34. Fuster V, Bowie EJW, Lewis JC, Fass DN, Owen CA Jr, Brown AL. Resistance to arteriosclerosis in pigs with von Willebrand's disease. J Clin Invest. 1978;61:722-730.
35. Nichols TC, Belinger DA, Tate DA, Reddick RL, Read MS, Koch GG, Brinkhous KM, Griggs TR. Von Willebrand factor and occlusive arterial thrombosis: study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis. 1990;10:449-461.